Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment (2023)
Attributed to:
MICA: The North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/psp4.13097
Publication URI: http://dx.doi.org/10.1002/psp4.13097
Type: Journal Article/Review
Parent Publication: CPT: Pharmacometrics & Systems Pharmacology